Support MPCC

1 out of 36 men will die of prostate cancer. Get involved.

Our Mission

Our Mission

The Massachusetts Prostate Cancer Coalition (MPCC) educates, connects, and supports men-at-risk, newly diagnosed individuals, survivors, and their families. It also connects organizations and professionals in Massachusetts that seek to conquer and cure prostate cancer.

Our Vision: Educate | Inform | Advocate

 

State of the Art — State of the Disease

Friday, May 12, 2017, Boston Marriott Copley Place, Boston, MA
Go here for the program brochure and here to register.

Five Facts about Prostate Cancer

Five Facts about Prostate Cancer
  1. 1
    Prevalence
    Prostate cancer is the most common (non-skin) cancer in American men, representing 33% of all new cases.
  2. 2
    Prostate cancer affects 1 in 7 men.
    1 in 7 men will be diagnosed with prostate cancer during their lifetime. In 2015, nearly 6,000 men were diagnosed with prostate cancer in Massachusetts, with an incidence rate of 4%-6% higher than the national average.
  3. 3
    Second leading cause of cancer death in men.
    Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. 
  4. 4
    Prostate cancer top risk factors.

    Ethnicity

    African-American men are twice as likely to die of prostate cancer as white men. Asian-Americans and Hispanic/Latinos have lower rates of prostate cancer than non-Hispanic white men.

    Age

    Prostate cancer occurs mainly in older men. About 6 cases in 10 are diagnosed in men aged 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66.

  5. 5
    This year over 27,000 men will die of prostate cancer.

    Yet, most men diagnosed with prostate cancer will not die from it. In fact, more than 2.5 million men in the United States who have been diagnosed with prostate cancer are still alive today.


Statistics from The American Cancer Society 2017

We need your support! Become a Member or Donate to MPCC today.

Symposium Schedule

Symposium Schedule

7:00AM Registration & Breakfast

8:00 Greetings & Welcome

8:15 Panel on Prevention & Screening
Peter C. Albertsen, MD, J. Jacques Carter, MD, Marc B. Garnick, MD, Andrew Vickers, Ph.D., moderator

9:30 Break

9:45 Panel on Active Surveillance & Early Stage Disease
Adam S. Kibel, MD, Eric A. Klein, MD, Laurence Klotz, MD, moderator; Kent W. Mouw, MD, Clare M. Tempany, MD

11:00 Break

11:15 Presentation of Austin & Colbert Awards
Charles Austin Award presented to Fran and Stan Klein
Jack Colbert Memorial Award presented to Dr. Marc Garnick

11:30 Panel on Metastatic Disease & Research
Glenn Bubley, MD, moderator, William G. Nelson, MD, Susan F. Slovin, MD

1:00PM Closing

 

In this patient education video, Dr. Jorge A. Garcia provides an introductory explanation of prostate cancer, its treatment options, and advances in treatment and research. Read more  read more →

Boston, MA (UroToday.com) The relationship between diabetes mellitus and metabolic syndrome with prostate cancer continues to be of debate. Recent literature sites metformin (an anti-hyperglycemic medication) to be able to modify gene expression in prostate cancer cells, with its attendant impact on lowering prostate-specific antigen (PSA) levels in the blood. Read more  read more →